{"id":15830,"name":"Bioqube Ventures","slug":"bioqube-ventures","website":"https://www.bioqubeventures.com/","hqGeo":"Belgium, United States","stageFocus":["Seed","Series A","Series B"],"sectorTags":["Healthcare"],"excludedSectors":[],"checkSizeMin":null,"checkSizeMax":null,"thesisSummary":"Invests in companies developing first- or best-in-class therapeutics to address major unmet medical needs. Strong biotech specialist, though primarily therapeutics-focused.","thesisNarrative":null,"logoUrl":null,"aumUsd":150000000,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"actithera","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"anavo therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Drug discovery company focused on human phosphatase biology and allosteric phosphatase modulators","amountUsd":null,"relevanceNote":null,"fundName":"Bioqube Factory Fund I"},{"companyName":"bicara therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"caelus health","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"calypso biotech","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"catalym","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Biopharma company developing cancer immunotherapy programs","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"commit biologics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"egle therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"enhanc3d genomics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Functional genomics company developing technology to unlock the human 3D genome for therapeutic development","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"primmune therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Biotech company harnessing the innate immune system","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"s biomedic","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"spica therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"syndesi therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"synox therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"tridek one","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Metrion Biosciences","companyUrl":null,"stage":"Collaboration/incubation backed by fund, not a standard priced round","sector":"Drug discovery / CRO","investmentYear":null,"description":"Specialist ion channel contract research and drug discovery company; the collaboration was backed by Bioqube Factory Fund I","amountUsd":null,"relevanceNote":null,"fundName":"Bioqube Factory Fund I"}],"partnerCount":9,"partners":[{"id":51645,"name":"Jon Edwards","title":"Managing Partner","seniority":null,"focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51648,"name":"Dirk Dumont","title":"President And Ceo","seniority":null,"focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51650,"name":"Roderick Verhelst","title":"Principal","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/roderick-verhelst-phd-mba-10811887","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51653,"name":"Geert Tackaert","title":"Finance Director","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/geert-tackaert-1410461b","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51654,"name":"Odile Rundquist","title":"Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/odile-rundquist-phd-88a34b28","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51655,"name":"Unknown","title":"Partner","seniority":null,"focusTags":["Therapeutics","Biotech"],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51647,"name":"Nico Vandervelpen","title":"Co-Founder","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/nico-vandervelpen-7772814","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51652,"name":"Tom Heyman","title":"Executive Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/tom-heyman-a652a51b8","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":52574,"name":"Bonnie van Wilgenburg","title":"Venture Partner","seniority":null,"focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[{"id":1024,"name":"Bioqube Ventures Fund III","vintageYear":2023,"sizeUsd":50000000,"status":"investing","focusAreas":[]},{"id":1023,"name":"Bioqube Ventures Fund II","vintageYear":2021,"sizeUsd":15000000,"status":"fully deployed","focusAreas":[]},{"id":1022,"name":"Bioqube Ventures Fund I","vintageYear":2018,"sizeUsd":100000000,"status":"fully deployed","focusAreas":[]}],"activity":{"lastInvestmentYear":null,"investmentsThisYear":0},"activityItems":[{"kind":"fund","title":"Raised Bioqube Ventures Fund III ($50M)","url":null,"source":"fund records","occurredAt":"2023-06-30T00:00:00.000Z"},{"kind":"fund","title":"Raised Bioqube Ventures Fund II ($15M)","url":null,"source":"fund records","occurredAt":"2021-06-30T00:00:00.000Z"},{"kind":"fund","title":"Raised Bioqube Ventures Fund I ($100M)","url":null,"source":"fund records","occurredAt":"2018-06-30T00:00:00.000Z"}],"contentUpdatedAt":"2026-10-27T01:31:35.821Z","investorType":"vc","preferredApproach":"warm intro preferred","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":11323,"name":"Mountain Pine Capital","slug":"mountain-pine-capital","logoUrl":null,"website":"https://mountainpineholdings.com/","stageFocus":["Seed"],"sectorTags":["Consumer","Healthcare","Real Estate"],"hqGeo":"Salt Lake City, UT"},{"id":12955,"name":"Jovono","slug":"jovono","logoUrl":null,"website":"https://jovono.com","stageFocus":["Seed","Series A"],"sectorTags":["Climate / Energy","Fintech","Consumer","SaaS","Healthcare"],"hqGeo":"Los Angeles, CA"},{"id":12160,"name":"Solid Ventures","slug":"solid-ventures","logoUrl":null,"website":"https://www.solidventures.vc/","stageFocus":["Seed"],"sectorTags":["Fintech","Healthcare","SaaS","Enterprise","Developer Tools","Consumer"],"hqGeo":"Austin, TX"},{"id":13026,"name":"Robin Capital","slug":"robin-capital","logoUrl":null,"website":"https://robincap.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["AI / ML","Fintech","SaaS","Climate / Energy","Healthcare"],"hqGeo":"Berlin, Germany"},{"id":12096,"name":"TeleHealth Ventures","slug":"telehealth-ventures","logoUrl":null,"website":"https://telehealthventures.com","stageFocus":["Seed"],"sectorTags":["Healthcare"],"hqGeo":"Austin, TX"},{"id":2457,"name":"Equilibrium Ventures","slug":"equilibrium-ventures","logoUrl":null,"website":"https://equilibrium.co/","stageFocus":["Seed"],"sectorTags":["Developer Tools","Healthcare"],"hqGeo":"Portland, OR"}],"featuredIn":[{"slug":"seed","displayName":"Seed Investors","pageType":"stage"},{"slug":"series-a","displayName":"Series A Investors","pageType":"stage"},{"slug":"healthcare","displayName":"Healthcare Investors","pageType":"industry"},{"slug":"series-b","displayName":"Series B Investors","pageType":"stage"}],"fundraisingResources":[{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"},{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"},{"slug":"what-vcs-actually-look-for-pitch-deck","title":"What VCs Actually Look for in a Pitch Deck"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-10-25T15:29:16.354Z"}